JPRN-jRCT2031210214已完成1 期
A Single and Multiple Dose Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-1942 in Healthy Japanese Adult Participants
Tanaka Yoshiyuki0 个研究点目标入组 48 人开始时间: 2021年7月30日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old（—）
- 性别
- Male
入选标准
- •Healthy male aged 20 to 45 years old with BMI 18.5 to 25.0 kg/m2
排除标准
- •Has a history of clinically significant abnormalities or diseases
研究者
相似试验
招募中
1 期
Single and Multiple Dose Study of MK-1167 in Healthy Japanese ParticipantsDementia Alzheimer's typeJPRN-jRCT2031230399Tanaka Yoshiyuki64
进行中（未招募）
1 期
Single and Multiple Dose Study of MK-0616 in Healthy Japanese ParticipantsHypercholesterolemiaJPRN-jRCT2031210233Tanaka Yoshiyuki48
已完成
1 期
Single and Multiple Dose Study of MK-5475 in Healthy ParticipantsPulmonary HypertensionJPRN-jRCT2031210073Tanaka Yoshiyuki48
进行中（未招募）
1 期
Single Dose Study of MK-2060 in Healthy Japanese ParticipantsPrevention of thrombotic vascular eventsJPRN-jRCT2031220658Tanaka Yoshiyuki48
已完成
1 期
A study in healthy subjects to see the effects of the test medicine ALKS 2680 in single and multi-dose regimePhase 1 drug studyNervous System DiseasesISRCTN98204977Alkermes (United States)147